Smith+Nephew received FDA 510(k) clearance to market the AETOS Shoulder System.
AETOS offers a compact, comprehensive portfolio of solutions that enable intraoperative flexibility. With fewer steps for conversion and fewer instruments for primary anatomic and reverse, the system is designed to simplify the operating room flow.
“This platform is the culmination of years of research and development and represents our commitment to providing healthcare professionals with the best possible technology for their patients. We are confident that this platform will further evolve the standard of care for shoulder surgery and are excited to see the impact it has on patient outcomes,” commented Brad Cannon, President Global Orthopaedics for Smith+Nephew.
Smith+Nephew received FDA 510(k) clearance to market the AETOS Shoulder System.
AETOS offers a compact, comprehensive portfolio of solutions that enable intraoperative flexibility. With fewer steps for conversion and fewer instruments for primary anatomic and reverse, the system is designed to simplify the operating room flow.
“This...
Smith+Nephew received FDA 510(k) clearance to market the AETOS Shoulder System.
AETOS offers a compact, comprehensive portfolio of solutions that enable intraoperative flexibility. With fewer steps for conversion and fewer instruments for primary anatomic and reverse, the system is designed to simplify the operating room flow.
“This platform is the culmination of years of research and development and represents our commitment to providing healthcare professionals with the best possible technology for their patients. We are confident that this platform will further evolve the standard of care for shoulder surgery and are excited to see the impact it has on patient outcomes,” commented Brad Cannon, President Global Orthopaedics for Smith+Nephew.
Copy to clipboard 
